Cargando…
Management Strategies and Outcomes for VHL-related Craniospinal Hemangioblastomas
Hemangioblastomas are rare and benign tumors accounting for less than 2% of all central nervous system (CNS) tumors. The vast majority of hemangioblastomas occur sporadically, whereas a small number of cases, especially in younger patients, are associated with Von Hippel–Lindau (VHL) syndrome. It is...
Autores principales: | Ordookhanian, Christ, Kaloostian, Paul E., Ghostine, Samer S., Spiess, Philippe E., Etame, Arnold B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Codon Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573741/ https://www.ncbi.nlm.nih.gov/pubmed/28868236 http://dx.doi.org/10.15586/jkcvhl.2017.90 |
Ejemplares similares
-
Anti-coagulation Drug Warfarin Contributes to Severe Adverse Outcomes in Prolonged Unsupervised Use: A Double-edged Sword
por: Ordookhanian, Christ, et al.
Publicado: (2018) -
Trauma-induced Acute Epidural Hematoma: The Rising Sun in a Progressively Lethargic Man
por: Ordookhanian, Christ, et al.
Publicado: (2018) -
Sporadic hemangioblastomas are characterized by cryptic VHL inactivation
por: Shankar, Ganesh M, et al.
Publicado: (2014) -
Improving C1-C2 Complex Fusion Rates: An Alternate Approach
por: Ghostine, Samer S, et al.
Publicado: (2017) -
Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma
por: Kruizinga, Roeliene C., et al.
Publicado: (2016)